A vaginal fluid simulant - PubMed (original) (raw)
Review
A vaginal fluid simulant
D H Owen et al. Contraception. 1999 Feb.
Abstract
A fluid medium was developed to simulate the fluid produced in the human vagina. The composition of the medium was based on an extensive review of the literature on constituents of human vaginal secretions. In choosing the ingredients for this medium, the goal was to emphasize properties that influence interactions of vaginal fluid with topical contraceptive, prophylactic, or therapeutic products. Among these properties, pH and osmolarity play a dominant role in physicochemical processes that govern drug release and distribution.
PIP: This article investigates a vaginal fluid simulant intended to model the fluid properties originating in the vagina--specifically the vaginal transudite found in healthy, nonpregnant premenopausal women. Methods of volume measurement of vaginal fluid fell into two categories: those that measured the quantity of vaginal fluid present at any one time and those that measured production over an extended interval. A volume of 0.75 ml vaginal fluid simulant was used. The proposed simulant was designed to incorporate information about chemical composition determined by previous researchers; this information emphasized pH modeling and the osmolarity of the material. Consequently, the specific "recipe" for 1 liter of this simulant given as compound and weight (g) was as follows: NaCl, 3.51; KOH, 1.40; Ca(OH)2, 0.222; borine serum albumin, 0.018; lactic acid, 2.00; acetic acid, 1.00; glycerol, 0.16; urea, 0.4; glucose, 5.0. The simulant was designed to have the same physical and chemical properties as those known to influence intravaginal gel efficacy. Further efforts by other researchers are needed if improved simulants are to be developed.
Similar articles
- A review of the physical and chemical properties of human semen and the formulation of a semen simulant.
Owen DH, Katz DF. Owen DH, et al. J Androl. 2005 Jul-Aug;26(4):459-69. doi: 10.2164/jandrol.04104. J Androl. 2005. PMID: 15955884 Review. - Engineering and characterization of simplified vaginal and seminal fluid simulants.
Rastogi R, Su J, Mahalingam A, Clark J, Sung S, Hope T, Kiser PF. Rastogi R, et al. Contraception. 2016 Apr;93(4):337-346. doi: 10.1016/j.contraception.2015.11.008. Epub 2015 Nov 14. Contraception. 2016. PMID: 26585883 Free PMC article. - Formulation and evaluation of metronidazole acid gel for vaginal contraception.
El-Gizawy SA, Aglan NI. El-Gizawy SA, et al. J Pharm Pharmacol. 2003 Jul;55(7):903-9. doi: 10.1211/0022357021350. J Pharm Pharmacol. 2003. PMID: 12906747 Clinical Trial. - Diaphragm insertion increases human vaginal oxygen tension.
Wagner G, Levin RJ, Bohr L. Wagner G, et al. Am J Obstet Gynecol. 1988 May;158(5):1040-3. doi: 10.1016/0002-9378(88)90214-1. Am J Obstet Gynecol. 1988. PMID: 3369481 - The effectiveness of barrier methods of contraception with and without spermicide.
Craig S, Hepburn S. Craig S, et al. Contraception. 1982 Oct;26(4):347-59. doi: 10.1016/0010-7824(82)90102-0. Contraception. 1982. PMID: 6759027 Review.
Cited by
- Griffithsin-Modified Electrospun Fibers as a Delivery Scaffold To Prevent HIV Infection.
Grooms TN, Vuong HR, Tyo KM, Malik DA, Sims LB, Whittington CP, Palmer KE, Matoba N, Steinbach-Rankins JM. Grooms TN, et al. Antimicrob Agents Chemother. 2016 Oct 21;60(11):6518-6531. doi: 10.1128/AAC.00956-16. Print 2016 Nov. Antimicrob Agents Chemother. 2016. PMID: 27550363 Free PMC article. - Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective.
Brotman RM. Brotman RM. J Clin Invest. 2011 Dec;121(12):4610-7. doi: 10.1172/JCI57172. Epub 2011 Dec 1. J Clin Invest. 2011. PMID: 22133886 Free PMC article. Review. - Modeling of Virion Collisions in Cervicovaginal Mucus Reveals Limits on Agglutination as the Protective Mechanism of Secretory Immunoglobulin A.
Chen A, McKinley SA, Shi F, Wang S, Mucha PJ, Harit D, Forest MG, Lai SK. Chen A, et al. PLoS One. 2015 Jul 1;10(7):e0131351. doi: 10.1371/journal.pone.0131351. eCollection 2015. PLoS One. 2015. PMID: 26132216 Free PMC article. - In Vitro-In Vivo Correlation (IVIVC) Population Modeling for the In Silico Bioequivalence of a Long-Acting Release Formulation of Progesterone.
Tosca EM, Rocchetti M, Pérez E, Nieto C, Bettica P, Moscoso Del Prado J, Magni P, De Nicolao G. Tosca EM, et al. Pharmaceutics. 2021 Feb 12;13(2):255. doi: 10.3390/pharmaceutics13020255. Pharmaceutics. 2021. PMID: 33673306 Free PMC article. - A curcumin-loaded liquid crystal precursor mucoadhesive system for the treatment of vaginal candidiasis.
Salmazi R, Calixto G, Bernegossi J, Ramos MA, Bauab TM, Chorilli M. Salmazi R, et al. Int J Nanomedicine. 2015 Jul 30;10:4815-24. doi: 10.2147/IJN.S82385. eCollection 2015. Int J Nanomedicine. 2015. PMID: 26257519 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources